Potential SARS-CoV-2 nonstructural proteins inhibitors: drugs repurposing with drug-target networks and deep learning.

Journal: Frontiers in bioscience (Landmark edition)
Published Date: Apr 1, 2022

Abstract

BACKGROUND: In the current COVID-19 pandemic, with an absence of approved drugs and widely accessible vaccines, repurposing existing drugs is vital to quickly developing a treatment for the disease.

Authors

  • Shayan K Azmoodeh
    REHS Program, San Diego Supercomputer Center, University of California, San Diego, CA 92093-0505, USA.
  • Igor F Tsigelny
    San Diego Supercomputer Center, University of California at San Diego, La Jolla, CA 92093, USA.
  • Valentina L Kouznetsova
    San Diego Supercomputer Center, University of California at San Diego, La Jolla, CA 92093, USA.

Keywords

External Resources

Popular Topics
Recent Journals